Benitec Biopharma
BNTC
BNTC
4 hedge funds and large institutions have $198K invested in Benitec Biopharma in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$113K |
Top Sellers
| 1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$85K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $113K | 28,690 | +12,934 | +82% |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $85K | 21,592 | -96,693 | -82% |
|
|
3
UBS Group
Zurich,
Switzerland
| – | – | -1,079 | Closed |
|
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $0 | 87 | -263 | -75% |
|
|
CFGS
5
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
6
JPMorgan Chase & Co
New York
| $0 | 100 | +100 | New |
|